The Expression of Autophagy Markers Beclin۱ and LC۳B in Prostatic Carcinoma: Immunohistochemical Case-Control Study
Publish place: IRANIAN JOURNAL of PATHOLOGY، Vol: 17، Issue: 1
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 91
This Paper With 10 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJP-17-1_011
تاریخ نمایه سازی: 14 بهمن 1400
Abstract:
Background and Objective: Prostatic carcinoma represents the second most common cancer diagnosed in men worldwide after lung cancer and the fourth common male malignancy in Egypt. Autophagy is a natural process that has both oncogenic and tumor-suppressive activities. This study aims to evaluate the role of Beclin۱ and LC۳B in prostatic carcinoma.Methods: This retrospective case-control study was conducted on ۱۱۰ prostate biopsies divided into two groups (۵۵ prostatic carcinoma, ۴۵ pure benign prostatic hyperplasia (BPH), and ۱۰ BPH with adjacent prostatic carcinoma) retrieved from the archive of the Pathology Department, Faculty of Medicine, Menoufia University, in the period between ۲۰۱۷ and ۲۰۲۰. All cases were stained for Beclin۱ and LC۳B antibodies. Results: There was a highly significant association between higher Beclin۱ and LC۳B immunoreactivity score and Gleason score (score ۸ and ۹) (P=۰.۰۰۲ and ۰.۰۰۰, respectively). Moreover, there was a highly significant direct association between Beclin۱ and LC۳B expression (r=۰.۵۲, P=۰.۰۰۰). Also, there was a significant stepwise increase in Beclin۱ positivity among the three studied groups starting from BPH to prostatic carcinoma passing through cases of BPH with neighboring tumor (P=۰.۰۰۰).Conclusion: From the results obtained in the present study, autophagy markers Beclin۱ and LC۳B were upregulated in prostatic carcinoma. Moreover, both were associated with bad prognostic factors. So, it might be necessary to control autophagy flux in prostatic carcinoma. This might be one of the future therapeutic targets for the management of prostatic carcinoma.
Keywords:
Authors
Nanis Shawky Holah
Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt
Marwa Mohammed Serag El-Dien
Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt
Shereen Fathy Mahmoud
Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :